NIH-funded research R21 grant

Investigating new treatments for genetic epilepsy using zebrafish models

Official title: Deep Behavioral Phenotyping of Novel Zebrafish Epilepsy Models

Funded at University of California, San Francisco · NIH-10943858 · Data updated 2026-11-12

This study is looking at genetic forms of epilepsy that cause tough seizures and behavior problems, using zebrafish to help find new treatments that might work better for people who don’t respond to current medications.

More Epilepsy research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startJuly 1, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$451,000
NIH project number1R21NS138525-01
Project IDNIH-10943858 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with genetic forms of epilepsy who have not responded well to existing treatments.

Less likely to help

Patients with non-genetic forms of epilepsy or those who have already found effective treatments may not benefit from this research.

What this research studies

This research focuses on understanding genetic epilepsies, which cause severe seizures and neurobehavioral issues in patients. By creating zebrafish models that mimic these conditions, researchers aim to explore the underlying mechanisms of epilepsy and identify potential new drug treatments. The study employs advanced imaging techniques and machine learning algorithms to analyze the behavior of these zebrafish mutants, facilitating large-scale drug screening. This innovative approach could lead to breakthroughs in managing epilepsy that is resistant to current medications.

Why it matters

Potential benefit: If successful, this research could lead to the development of new and effective treatments for patients with genetic epilepsy.

How similar studies have gone: Other research has shown promise in using animal models for drug discovery in epilepsy, making this approach both innovative and grounded in prior success.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Baraban, Scott C — University of California, San Francisco
  • Study coordinator: Baraban, Scott C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.